760 related articles for article (PubMed ID: 16441626)
1. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
Parsad D; Kanwar AJ; Kumar B
J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
[TBL] [Abstract][Full Text] [Related]
2. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
3. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
4. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
5. Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy.
Kanwar AJ; Dogra S; Parsad D; Kumar B
Int J Dermatol; 2005 Jan; 44(1):57-60. PubMed ID: 15663664
[TBL] [Abstract][Full Text] [Related]
6. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo.
Hartmann A; Lurz C; Hamm H; Bröcker EB; Hofmann UB
Int J Dermatol; 2005 Sep; 44(9):736-42. PubMed ID: 16135141
[TBL] [Abstract][Full Text] [Related]
7. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides.
El-Mofty M; Mostafa WZ; Bosseila M; Youssef R; Esmat S; El Ramly A; Fawzi M; Mahgoub D; Nagui N; Mashaly HM; El-Fangary M; Fathy M
Dermatol Ther; 2010; 23(4):428-34. PubMed ID: 20666832
[TBL] [Abstract][Full Text] [Related]
8. Systemic PUVA vs. narrowband UVB in the treatment of vitiligo: a randomized controlled study.
Sapam R; Agrawal S; Dhali TK
Int J Dermatol; 2012 Sep; 51(9):1107-15. PubMed ID: 22909369
[TBL] [Abstract][Full Text] [Related]
9. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UV-A.
Westerhof W; Nieuweboer-Krobotova L
Arch Dermatol; 1997 Dec; 133(12):1525-8. PubMed ID: 9420536
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area.
Welsh O; Herz-Ruelas ME; Gómez M; Ocampo-Candiani J
Int J Dermatol; 2009 May; 48(5):529-34. PubMed ID: 19416388
[TBL] [Abstract][Full Text] [Related]
11. Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy.
Brazzelli V; Antoninetti M; Palazzini S; Barbagallo T; De Silvestri A; Borroni G
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1369-74. PubMed ID: 17958843
[TBL] [Abstract][Full Text] [Related]
12. Comparison of systemic PUVA and NB-UVB in the treatment of vitiligo: an open prospective study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 May; 21(5):638-42. PubMed ID: 17447977
[TBL] [Abstract][Full Text] [Related]
13. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
14. Calcipotriol and PUVA as treatment for vitiligo.
Cherif F; Azaiz MI; Ben Hamida A; Ben O; Dhari A
Dermatol Online J; 2003 Dec; 9(5):4. PubMed ID: 14996377
[TBL] [Abstract][Full Text] [Related]
15. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo.
Scherschun L; Kim JJ; Lim HW
J Am Acad Dermatol; 2001 Jun; 44(6):999-1003. PubMed ID: 11369913
[TBL] [Abstract][Full Text] [Related]
16. Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects.
Lotti T; Buggiani G; Troiano M; Assad GB; Delescluse J; De Giorgi V; Hercogova J
Dermatol Ther; 2008 Jul; 21 Suppl 1():S20-6. PubMed ID: 18727812
[TBL] [Abstract][Full Text] [Related]
17. Changes in the dermoscopic appearance of melanocytic naevi after photochemotherapy or narrow-band ultraviolet B phototherapy.
Kilinc Karaarslan I; Teban L; Dawid M; Tanew A; Kittler H
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):526-31. PubMed ID: 17373982
[TBL] [Abstract][Full Text] [Related]
18. Broadband targeted UVB phototherapy for localized vitiligo: a retrospective study.
Akar A; Tunca M; Koc E; Kurumlu Z
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):161-3. PubMed ID: 19438998
[TBL] [Abstract][Full Text] [Related]
19. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
Bansal S; Sahoo B; Garg V
Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vitiligo with broadband ultraviolet B and vitamins.
Don P; Iuga A; Dacko A; Hardick K
Int J Dermatol; 2006 Jan; 45(1):63-5. PubMed ID: 16426381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
